Eschbach, Ralf S <br/><br/>
Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.  [electronic resource] 

 -  PloS one  2015 
 - e0115543 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0115543  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Colonic Neoplasms--drug therapy<br/>Drug Monitoring--methods<br/>Female<br/>Fluorodeoxyglucose F18<br/>Heterografts--pathology<br/>Humans<br/>Immunohistochemistry--methods<br/>Magnetic Resonance Angiography--methods<br/>Neoplasms, Experimental--drug therapy<br/>Phenylurea Compounds--therapeutic use<br/>Positron-Emission Tomography--methods<br/>Pyridines--therapeutic use<br/>Rats<br/>Rats, Nude